SMAD6 Polyclonal Antibody
- Molecular Weight: 0
- Update Date: 2025-08-20 16:56:09
What is SMAD6 Polyclonal Antibody?
Description
SMADs are a family of intracellular proteins that are essential components in the signaling pathways of the serine/threonine kinase receptors of the transforming growth factor β superfamily. SMADs can be divided into receptor-
Safety information for SMAD6 Polyclonal Antibody
New Products
Dexamethasone Sodium Phosphate 2-(2-Ethoxyphenoxy)ethyl bromide 8-Bromo-7-(2-butynyl)-3-methyl xanthine 5-Chlorothiophene-2-carboxylic acid m-Tolualdehyde p-Anisaldehyde 2-Bromobenzaldehyde 4-Fluorobenzaldehyde 1-Propyl-4-piperidone 3-Amino-3-(3-fluorophenyl)propanoic acid 2-Fluoro-6-iodobenzoic acid 3-(4-Bromo-3-methyl-2-oxo-2,3-dihydro-1h-benzo[d]imidazol-1-yl)piperidine-2,6-dione 2,3-Dihydro-5,6-dimethoxy-2-(4-piperidinylmethyl)-1H-inden-1-one hydrochloride ethyl 2-oxo-2,3,9,10-tetrahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline-8(7H)-carboxylate 1-Boc-4-cyanopiperidine 3-Pyridineacrylic acid Abiraterone Ethyl Ether Vardenafil Bis-sulphonamide(Dimer) 1-nitro-3,5-dimethyl adamantine (NMEM) 3-(2-aminoethyl) benzene sulfonamide Nabumetone Impurity 5 2,2-dibromo-1-cyclopropyl-2-(2-fluorophenyl)ethan-1-one 2-Amino-3,5-Dichloro-4-picoline 5-Amino-2-EthoxypyridineYou may like
-
141-30-0 3,6-Dichloropyridazine 98%View Details
141-30-0 -
Ethyl 2-chloro-2-(2-(4-methoxyphenyl)hydrazono)acetate 27143-07-3 98%View Details
27143-07-3 -
94-71-3 98%View Details
94-71-3 -
Methyl 2-methoxy-5-sulfamoylbenzoate 33045-52-2 98%View Details
33045-52-2 -
88965-00-8 98%View Details
88965-00-8 -
3,6-Dichloro-4-Isopropylpyridazine 107228-51-3 98%View Details
107228-51-3 -
4640-67-9 98%View Details
4640-67-9 -
2-[(2-Ethoxyphenoxy)methyl]oxirane 98%View Details
5296-35-5
Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.